Ingrezza (Valbenazine Tosylate) is a prescription medication used to treat tardive dyskinesia and for the treatment of involuntary body movement (chorea) associated with Huntington's disease in older people with these conditions. The active ingredient in Ingrezza is Valbenazine Tosylate, which belongs to the class of medication called vesicular monoamine transporter 2 (VMAT2) in neurons. As a result, it decreases the amount of dopamine in the nerve endings in the brain, which helps control body movements. It would be best to know that Ingrezza controls the symptoms of movement disorders but does not cure the conditions.
Manufacturer Information
We currently offer the brand Ingrezza from Canada manufactured by Neurocrine Biosciences (unavailable). The generic equivalent is not available at the moment.
Get medical help immediately if you have any signs of an allergic reaction while using Ingrezza. The most common side effects of Ingrezza may include the following:
• Arthralgia;
• Loss of balance while walking;
• Nausea and vomiting;
• Rash
br>br>
Contact your doctor right away if you have any of the severe side effects, including:
• Angioedema involving the larynx, glottis, lips, and eyelids a few minutes to hours after taking this medicine;
• Excessive sleepiness during the day;
• Hypersensitivity reactions, including cases of angioedema involving the larynx, glottis, lips, and eyelids;
• Thought of harming yourself;
• Worsening of y our condition
br>br>
These are not all of Ingrezza's side effects. Always contact your doctor if you notice any unusual symptoms.
You should not use Ingrezza if you are allergic to any ingredient in Ingrezza or if you are taking, or have stopped taking, a MAOI within the last 14 days. Before you start using this medication, tell your doctor about your medical history, especially if you:
• Are breastfeeding or planning to breastfeed;
• Are pregnant or planning to become pregnant;
• Have depression or psychotic disorder;
• Have diabetes;
• Have Huntington's disease;
• Have kidney disease;
• Have liver disease
Tell your doctor about all your medications, including prescription, OTC, herbal supplements, and vitamins. There may be drug interactions between Ingrezza and other medicines, such as deutetrabenazine and tetrabenazine. Tell your doctor if you are pregnant or planning to become pregnant. Ingrezza can harm the unborn baby. Discuss with your doctor immediately after you become pregnant. Breastfeeding is not recommended while taking an Ingrezza capsule. Do not breastfeed while using this medicine and for at least five days after your last dose. Ingrezza is a capsule that should be taken orally with a cup of water. The usual dose of Ingrezza is one capsule daily, with or without food. Take this medicine exactly as prescribed by your doctor. Follow all directions on your prescription label carefully and ask your doctor to explain anything you do not understand about your treatment. Depending on the severity of your condition, your doctor may start you on a low dose of Ingrezza and increase it gradually depending on how well you respond to treatment. While taking Ingrezza, do not drive a car or operate dangerous machinery until you know how Ingrezza affects you. Drinking alcohol and taking other drugs that may also cause sleepiness while you are taking Ingrezza may increase any sleepiness caused by Ingrezza. Do not stop taking this medicine without first asking your doctor. Speak to your doctor if you notice your condition is getting worse. Store the medicine out of the reach of children.